Teleflex Incorporated (TFX) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally.

Total Cash From Operating Activities Chart for Teleflex Incorporated

Teleflex Incorporated (TFX) operating cash flow for FY2025 was USD 340.7M, a -46.4% change from FY2024. Teleflex Incorporated's operating cash flow grew from USD 21.7M in 1989 to USD 340.7M in 2025 (1469.9% over 36 years). Operating cash flow compound annual growth rate: 5-year CAGR of -4.8%, 10-year CAGR of 1.3%, 20-year CAGR of 0.1%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.